Investigating the causes of late-stage liver cancer in low-income areas
Multilevel Determinants of Socioeconomic Disparities in Geographic Late Stage Hepatocellular Carcinoma Hotspots
This study is looking into why late-stage liver cancer is more common in low-income neighborhoods, and it aims to find out what makes it harder for people in these areas to get early treatment, so we can help improve their care and outcomes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project ID | NIH-10811702 on NIH RePORTER |
What this research studies
This research focuses on understanding why late-stage hepatocellular carcinoma (HCC) is more prevalent in low-income communities. By analyzing data from cancer registries and conducting interviews with patients and healthcare providers, the study aims to identify the factors contributing to these disparities. The researchers will use advanced geospatial techniques to pinpoint areas with the highest rates of late-stage HCC and explore barriers to early detection and treatment. This comprehensive approach seeks to inform targeted interventions that can improve cancer outcomes in disadvantaged populations.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with hepatocellular carcinoma, particularly those from low socioeconomic backgrounds.
Not a fit: Patients with early-stage liver cancer or those from higher socioeconomic backgrounds may not benefit directly from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved early detection and treatment strategies for liver cancer in low-income communities.
How similar studies have performed: Previous research has shown success in addressing health disparities through targeted interventions in similar populations, indicating potential for impactful outcomes in this study.
Where this research is happening
Los Angeles, UNITED STATES
- University of Southern California — Los Angeles, United States (Active)
Researchers
- Principal investigator: Zhou, Kali — University of Southern California
- Study coordinator: Zhou, Kali
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.